Repligen Corporation (NASDAQ:RGEN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Glenn P. Muir Other companies: Cytek Biosciences, Inc. (Director · Since at least Jun 10, 2026); Neuronetics, Inc. (Board Member · Since at least Jun 27, 2018); G1 Therapeutics Inc (Director · May 16, 2017 – Sep 18, 2024 · Past); Lifeward Ltd. (Director · Dec 31, 2015 – Jun 27, 2017 · Past); Hologic Inc (Executive VP and CFO · Feb 1, 2006 – May 8, 2014 · Past) | Director · Since at least Sep 14, 2015 |
| Paul Schimmel Other companies: aTyr Pharma, Inc. (Director · Since at least May 6, 2015); Alnylam Pharmaceuticals, Inc. (Co-founder and member of the Board of Directors · Since at least Jan 31, 2006); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – Nov 30, 2007 · Past); Alkermes plc (Director · Mar 2, 2006 – Jun 15, 2007 · Past) | Director · Aug 11, 2006 – Jun 14, 2007 · Past |
| John Cox Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Bioverativ Inc (Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past) | Director · Nov 15, 2013 – Mar 24, 2020 · Past |
| Nicolas M. Barthelemy Other companies: 908 Devices Inc. (Director · Dec 17, 2020 – Jun 15, 2022 · Past); Twist Bioscience Corporation (Director · Oct 24, 2019 – Nov 21, 2022 · Past); Standard BioTools Inc. (Director · Mar 23, 2017 – Apr 1, 2022 · Past) | Director · Since at least May 11, 2016 |
| Martin Madaus Other companies: Azenta, Inc. (interim President and CEO · Since Aug 24, 2026); Haemonetics Corporation (Director · Since at least Jul 24, 2026) | Chair of the Board · Since at least Jan 6, 2026 |
| Tony Hunt Other companies: BioLife Solutions, Inc. (Director · Since at least Dec 20, 2024); 908 Devices Inc. (Director · Since at least Mar 2, 2022) | Director · Since at least Nov 19, 2020 |
| Glenn L Md Cooper Other companies: Fortress Biotech, Inc. (See Remarks, Director · Sep 13, 2011 – Nov 30, 2012 · Past) | Director · Sep 16, 2010 – May 23, 2019 · Past |
| Konstantin Konstantinov Other companies: Codiak BioSciences Inc (Chief Technology Officer · Oct 13, 2020 – Mar 28, 2023 · Past) | Director · Since at least May 26, 2022 |
| Manner Carrie Eglinton Other companies: OraSure Technologies, Inc. (President & CEO, Director · Since at least Jun 4, 2025) | Director · Since at least May 15, 2025 |
| Margaret Pax Other companies: Alimera Sciences Inc (Director · Nov 7, 2023 – Sep 16, 2024 · Past) | Director · Since at least Mar 18, 2024 |
| Rohin Mhatre Other companies: Parabilis Medicines, Inc. (Chief Technical Operations Officer · Since at least Jun 9, 2026) | Director · Since at least Mar 1, 2020 |
| Violetta Hughes Other companies: Azenta, Inc. (VP, Chief Accounting Officer · Aug 31, 2023 – Feb 3, 2025 · Past) | Chief Accounting Officer · Since at least Sep 1, 2025 |
| Alexander Rich | Director · Dec 15, 2011 – Dec 15, 2011 · Past |
| Alfred Lewis Goldberg | Director · Jul 1, 2008 – May 21, 2015 · Past |
| Brian Douglass | Senior Vice President and Chief Product Officer · Since at least May 7, 2026 |
| Carrie Eglinton Manner | Director · Since at least Nov 5, 2026 |
| Christine Gebski | See Remarks · Feb 25, 2021 – May 14, 2024 · Past |
| Earl Webb Henry | Director · Dec 12, 2007 – May 9, 2013 · Past |
| George Scott | Senior Vice President, General Counsel · Since at least Nov 4, 2026 |
| Greg Titus | Senior Vice President, Commercial Development · Since at least Nov 4, 2026 |
| Hal Landy | Vice President · Jun 19, 2007 – Jun 19, 2007 · Past |
| Heather Ems | Chief Information Officer · Since at least Nov 4, 2026 |
| Jacob Johnson | VP, Investor Relations · Since at least Apr 8, 2025 |
| James R. Bylund | Chief Operating Officer · Since at least Feb 25, 2021 |
| Jason K. Garland | Chief Financial Officer · Since at least Jun 25, 2026 |
| Jessica Hameline | Senior Vice President, Business Development & Strategy · Since at least Nov 4, 2026 |
| Jon Snodgres | Chief Financial Officer · Jul 14, 2015 – May 16, 2023 · Past |
| Karen A Dawes | Director · Since at least Feb 27, 2024 |
| Keng Hock Chua | Senior Vice President, Commercial for Asia · Since at least Nov 4, 2026 |
| Laura Whitehouse | Vice President · Feb 28, 2006 – May 10, 2007 · Past |
| Leslie Galvin | Vice President, Global Head, Human Resources · Since at least Nov 4, 2026 |
| Maggie A. Pax | Director · Since at least May 18, 2026 |
| Michael Hall | Chief Medical Officer · Mar 12, 2012 – Mar 12, 2012 · Past |
| Neil Whitfield | Senior Vice President, Sales · Since at least Nov 4, 2026 |
| Olivier Loeillot | Preseident and Chief Executive Officer · Since at least Oct 2, 2023 |
| Ralf Kuriyel | Senior Vice President, Research and Development · Since at least Feb 28, 2018 |
| Thomas F Ryan Jr | Director · Dec 9, 2005 – Mar 1, 2022 · Past |